Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in Juvenile idiopathic arthritis

Arthritis and Rheumatism

Volumn 65, Issue 8, 2013, Pages 2201-2210

  Dvergsten, Jeffrey A ^a,c   Mueller, Robert G ^a,d   Griffin, Patricia ^a,e   Abedin, Sameem ^a   Pishko, Allyson ^a,f   Michel, Joshua J ^a   Rosenkranz, Margalit E ^a   Reed, Ann M ^b   Kietz, Daniel A ^a   Vallejo, Abbe N ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b MAYO CLINIC   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^f DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HISTONE H2AX; HISTONE H2AX GAMMA; INTERLEUKIN 10; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL AGING; CELLULAR IMMUNITY; CHILD; EXOCYTOSIS; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SCHOOL CHILD; SYNOVIAL FLUID; T LYMPHOCYTE ACTIVATION; TELOMERE;

ADOLESCENT; ANTIGENS, CD28; ANTIGENS, CD31; ARTHRITIS, JUVENILE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL AGING; CELL PROLIFERATION; CHILD; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FETAL BLOOD; HISTONES; HUMANS; LYMPHOCYTE ACTIVATION; MALE; RECEPTORS, ANTIGEN, T-CELL; SYNOVIAL FLUID; T-LYMPHOCYTE SUBSETS; TELOMERE; TIME FACTORS;

EID: 84881360848     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.38015     Document Type: Article

References (50)

1. Macaubas C, Nguyen K, Milojevic D, Park JL, Mellins ED,. Oligoarticular and polyarticular JIA: epidemiology and pathogenesis. Nat Rev Rheumatol 2009; 5: 616-26.
2. Grom AA, Hirsch R,. T-cell and T-cell receptor abnormalities in the immunopathogenesis of juvenile rheumatoid arthritis. Curr Opin Rheumatol 2000; 12: 420-4.
3. Hashkes PJ, Uziel Y, Laxer RM,. The safety profile of biologic therapies for juvenile idiopathic arthritis. Nat Rev Rheumatol 2010; 6: 561-71.
4. Haufe S, Haug M, Schepp C, Kuemmerle-Deschner J, Hansmann S, Rieber N, et al. Impaired suppression of synovial fluid CD4+CD25- T cells from patients with juvenile idiopathic arthritis by CD4+CD25+ Treg cells. Arthritis Rheum 2011; 63: 3153-62.
5. Wedderburn LR, Maini MK, Patel A, Beverley PC, Woo P,. Molecular fingerprinting reveals non-overlapping T cell oligoclonality between an inflamed site and peripheral blood. Int Immunol 1999; 11: 535-43.
6. Lemster BH, Michel JJ, Montag DT, Paat JJ, Studenski SA, Newman AB, et al. Induction of CD56 and TCR-independent activation of T cells with aging. J Immunol 2008; 180: 1979-90.
7. Martens PB, Goronzy JJ, Schaid D, Weyand CM,. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum 1997; 40: 1106-14.
8. Martini A, Lovell DJ,. Juvenile idiopathic arthritis: state of the art and future perspectives. Ann Rheum Dis 2010; 69: 1260-3.
9. Martini A,. It is time to rethink juvenile idiopathic arthritis classification and nomenclature. Ann Rheum Dis 2012; 71: 1437-9.
10. Monteiro J, Batliwalla F, Ostrer H, Gregersen PK,. Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J Immunol 1996; 156: 3587-90.
11. Vallejo AN,. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005; 205: 158-69.
12. Sharpe AH,. Mechanisms of costimulation. Immunol Rev 2009; 229: 5-11.
13. Ramanathan S, Gagnon J, Dubois S, Forand-Boulerice M, Richter MV, Ilangumaran S,. Cytokine synergy in antigen-independent activation and priming of naive CD8+ T lymphocytes. Crit Rev Immunol 2009; 29: 219-39.
14. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-2.
15. Vallejo AN, Hamel DL Jr, Mueller RG, Ives DG, Michel JJ, Boudreau RM, et al. NK-like T cells and plasma cytokines, but not anti-viral serology, define immune fingerprints of resilience and mild disability in exceptional aging. PLoS One 2011; 6: e26558.
16. Mah LJ, El-Osta A, Karagiannis TC,. γH2AX as a molecular marker of aging and disease. Epigenetics 2010; 5: 129-36.
17. Sharpless NE, DePinho RA,. Telomeres, stem cells, senescence, and cancer. J Clin Invest 2004; 113: 160-8.
18. Baerlocher GM, Vulto I, de Jong G, Lansdorp PM,. Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc 2006; 1: 2365-76.
19. De Rosa SC, Herzenberg LA, Roederer M,. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med 2001; 7: 245-8.
20. Vallejo AN, Brandes JC, Weyand CM, Goronzy JJ,. Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. J Immunol 1999; 162: 6572-9.
21. Abedin S, Michel JJ, Lemster B, Vallejo AN,. Diversity of NKR expression in aging T cells and in T cells of the aged: the new frontier into the exploration of protective immunity in the elderly. Exp Gerontol 2005; 40: 537-48.
22. Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM,. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A 2000; 97: 9203-8.
23. Brunner J, Herrmann M, Metzler M, Gaipl U, Reuter G, Haas JP,. The turnover of synovial T cells is higher than in T cells in the peripheral blood in persistent oligoarticular juvenile idiopathic arthritis. Rheumatol Int 2010; 30: 1529-32.
24. Privratsky JR, Newman DK, Newman PJ,. PECAM-1: conflicts of interest in inflammation. Life Sci 2010; 87: 69-82.
25. Deaglio S, Mallone R, Baj G, Arnulfo A, Surico N, Dianzani U, et al. CD38/CD31, a receptor/ligand system ruling adhesion and signaling in human leukocytes. Chem Immunol 2000; 75: 99-120.
26. Weiss A, Stobo JD,. Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line. J Exp Med 1984; 160: 1284-99.
27. Eck SC, Chang D, Wells AD, Turka LA,. Differential down-regulation of CD28 by B7-1 and B7-2 engagement. Transplantation 1997; 64: 1497-9.
28. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002; 169: 1984-92.
29. Weitz M, Kiessling C, Friedrich M, Prosch S, Hoflich C, Kern F, et al. Persistent CMV infection correlates with disease activity and dominates the phenotype of peripheral CD8+ T cells in psoriasis. Exp Dermatol 2011; 20: 561-7.
30. Bate SL, Dollard SC, Cannon MJ,. Cytomegalovirus seroprevalence in the United States: the National Health and Nutrition Examination Surveys, 1988-2004. Clin Infect Dis 2010; 50: 1439-47.
31. Prelog M, Schwarzenbrunner N, Sailer-Hoeck M, Kern H, Koppelstaetter C, Wurzner R, et al. Indications for a disturbed peripheral T-cell homeostasis in juvenile idiopathic arthritis (JIA): absent expansion of CD28 T-cells and no decrease of naive T-cells in cytomegalovirus-positive patients with JIA. J Rheumatol 2008; 35: 520-7.
32. Michel JJ, Turesson C, Lemster B, Atkins SR, Iclozan C, Bongartz T, et al. CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis. Arthritis Rheum 2007; 56: 43-57.
33. Kimmig S, Przybylski GK, Schmidt CA, Laurisch K, Mowes B, Radbruch A, et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 2002; 195: 789-94.
34. - T cells in ankylosing spondylitis. Arthritis Res 2002; 4: 71-6.
35. + T cells in chronic plaque psoriasis are Tc1 cells producing heterogeneous levels of interferon-γ. Exp Dermatol 2001; 10: 168-74.
36. Chappert P, Schwartz RH,. Induction of T cell anergy: integration of environmental cues and infectious tolerance. Curr Opin Immunol 2010; 22: 552-9.
37. Prelog M, Schwarzenbrunner N, Sailer-Hock M, Kern H, Klein-Franke A, Ausserlechner MJ, et al. Premature aging of the immune system in children with juvenile idiopathic arthritis. Arthritis Rheum 2008; 58: 2153-62.
38. Weng NP,. Telomeres and immune competency. Curr Opin Immunol 2012; 24: 470-5.
39. Patil CK, Mian IS, Campisi J,. The thorny path linking cellular senescence to organismal aging. Mech Ageing Dev 2005; 126: 1040-5.
40. Odum N, Morling N, Platz P, Hofmann B, Ryder LP, Heilmann C, et al. Increased prevalence of late stage T cell activation antigen (VLA-1) in active juvenile chronic arthritis. Ann Rheum Dis 1987; 46: 846-52.
41. Jankovic D, Kugler DG, Sher A,. IL-10 production by CD4+ effector T cells: a mechanism for self-regulation. Mucosal Immunol 2010; 3: 239-46.
42. Dijke IE, Weimar W, Baan CC,. The control of anti-donor immune responses by regulatory T cells in organ transplant patients. Transplant Proc 2008; 40: 1249-52.
43. Davila E, Kang YM, Park YW, Sawai H, He X, Pryshchep S, et al. Cell-based immunotherapy with suppressor CD8+ T cells in rheumatoid arthritis. J Immunol 2005; 174: 7292-301.
44. + regulatory T cells, immune stimulation and host defence against infection. Immunology 2012; 136: 1-10.
45. Barnes MG, Grom AA, Thompson SD, Griffin TA, Pavlidis P, Itert L, et al. Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis. Arthritis Rheum 2009; 60: 2102-12.
46. Shahin AA, Shaker OG, Kamal N, Hafez HA, Gaber W, Shahin HA,. Circulating interleukin-6, soluble interleukin-2 receptors, tumor necrosis factor α, and interleukin-10 levels in juvenile chronic arthritis: correlations with soft tissue vascularity assessed by power Doppler sonography. Rheumatol Int 2002; 22: 84-8.
47. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P,. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42: 1101-8.
48. Vallejo AN,. Immune remodeling: lessons from repertoire alterations during chronological aging and in immune-mediated disease. Trends Mol Med 2007; 13: 94-102.
49. Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004; 21: 357-66.
50. Meyer-Olson D, Simons BC, Conrad JA, Smith RM, Barnett L, Lorey SL, et al. Clonal expansion and TCR-independent differentiation shape the HIV-specific CD8+ effector-memory T-cell repertoire in vivo. Blood 2010; 116: 396-405.